Texture and Color Enhancement Imaging (TXI) is a newly developed image-enhancing endoscopy technology that has show potential in improving detection of colorectal lesions. This multicenter, randomized, tandem trial is aimed at evaluating whether TXI is superior to WLI endoscopy in terms of diagnosis of premalignant lesions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Enrollment
2,964
Patients in Group A will undergo colonoscopy with TXI.
Patients in group B will first undergo colonoscopy with TXI and every polyp found should be removed. Then switch to WLI for a second withdrawal to detect lesions that were not observed the first time.
Patients in Group C will undergo colonoscopy with WLI.
adenoma detection rate
the number of patients with one or more adenomas detected and removed divided by the total number of patient
Time frame: 1 years
sessile serrated lesion detection rate
the number of patients with one or more sessile serrated lesions detected and removed divided by the total number of patients
Time frame: 1 years
adenoma miss rate
the number of adenomas detected during the second examination divided by the total number of adenomas detected during the first and second colonoscopy
Time frame: 1 years
sessile serrated lesion miss rate
the number of sessile serrated lesions detected during the second examination divided by the total number of sessile serrated lesions detected during the first and second colonoscopy
Time frame: 1 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Patients in group D will first undergo colonoscopy with WLI and every polyp found should be removed. Then switch to TXI for a second withdrawal to detect lesions that were not observed the first time.